The disease now referred to as splenic lymphoma with villous lymphocytes (SLVL)1 was previously described by Neiman et Splenic involvement is common in SCCL, and the spleen shows a miliary pattern of involvement on gross examination because of expansion of the white pulp, not unlike that seen in our case. Cytologically, however, SCCL shows a monotonous proliferation of lymphocytes with highly irregular nuclei (cleaved cells). Immunophenotypically, SCCL closely related, and we believe that the morphological features of the neoplastic cells supports this relationship.
We observed marked clumping of lymphoma cells in the peripheral blood smears prepared from EDTA anticoagulated blood. Such a phenomenon has been described in only one previous report, which incidentally described a patient with SLVL.8 These authors stated that this finding had never been described before, in either leukaemias or lymphomas involving the peripheral blood. The cause of this clumping remains uncertain but has been attributed to the presence of EDTA.
We believe that the most interesting aspect of this case is the occurrence of SLVL in a patient with family history of a B cell lymphoproliferative disorder. It is conceivable that the patient's brother and father also suffered from SLVL, particularly as we were able to find one previous report describing occurrence of SLVL in two sisters.9 However, with the limited material available for study on Hypobetalipoproteinaemia is a rare autosomal dominant condition characterised by low serum cholesterol concentrations. The exact biochemical defect is not known although truncated forms of apolipoprotein B (ApoB) have been described.' Heterozygotes tend to be asymptomatic, whereas homozygous individuals may present with neurological sequelae similar to individuals with abetalipoproteinaemia. Lp(a) lipoprotein is considered to be a cardiovascular risk factor, yet how it exerts this action is unclear; possibly it acts in part by counteracting the fibrinolytic system.2"
